Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells

7 Mar 2018

Abstract excerpt

PURPOSE: Targeting cancer cells by modulating the immune system has become an important new therapeutic option in many different malignancies. Inhibition of CTLA4/B7 and PD1/PDL1 signaling is now also being investigated and already successfully applied to various hematologic malignancies. METHODS: A literature review of PubMed and results of our own studies were compiled in order to give a comprehensive overview...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Lymphoma Diagnosis and Treatment
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29564225
DOI: 10.3389/fonc.2018.00054

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 22 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mechanisms of Immune Evasion and Immune Modulation by Lymphoma CellsPMID 29564225Read ↗

Malignant lymphoma: pathophysiology and current therapy.Semantic proximity Read ↗

The Hodgkin Lymphoma Immune Microenvironment: Turning Bad News into GoodSemantic proximity Read ↗

Immune Checkpoint Blockade and Biomarkers of Response in Lymphoma: A Case-Illustrated Narrative ReviewSemantic proximity Read ↗

Immune Checkpoint Inhibitors to Treat Malignant LymphomasSemantic proximity Read ↗

Genomic alterations underlying immune privilege in malignant lymphomasSemantic proximity Read ↗

Optimizing therapy for nodal marginal zone lymphomaSemantic proximity Read ↗

New targeted therapies for malignant lymphoma based on molecular heterogeneity.Semantic proximity Read ↗

Hodgkin Disease and the Role of the Immune SystemSemantic proximity Read ↗

Pathogenesis of Peripheral T Cell LymphomaSemantic proximity Read ↗

The molecular pathogenesis of primary mediastinal large B-cell lymphomaSemantic proximity Read ↗

Unraveling MCL biology to understand resistance and identify vulnerabilitiesSemantic proximity Read ↗

Mechanisms of B-cell lymphoma pathogenesis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.